Delivery Order SPE2DB20D3103-SPE2DB25FP8P9
- Not listed
- On September 8, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units). This firm fixed-price, non-set-aside delivery order is scheduled for completion by September 29, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for Orgovyx 120 mg tablets (quantity: 30 units) on July 17, 2025, with a completion date of August 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal healthcare vendor that serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,385.52 with firm fixed pricing and is scheduled for completion by August 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order, leveraging the company's extensive...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,313.12 on September 26, 2025, for the supply of Orgovyx 120 mg tablets (30-count unit dose packages). This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 20, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $8,313.12 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on May 27, 2025, with an ultimate completion date of June 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates Conshohocken, Pennsylvania as the place of performance, which is also the location of AmerisourceBergen's corporate headquarters. The delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on August 27, 2025, with an ultimate completion date of September 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Orgovyx 120 mg tablets in a quantity of 30 units, valued at $4,156.56 under a firm fixed-price contract structure. This delivery order is classified as non-set-aside and competitively awarded, with an ultimate completion date of June 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Orgovyx 120 mg tablets in a quantity of 30 units, valued at $4,156.56. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of October 9, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on October 17, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,385.52 and an ultimate completion date of November 7, 2025. The contract was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,385.52 with completion scheduled for September 23, 2025, represents a non-competitive award issued under an existing contract vehicle. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP8P9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract is valued at $4,156.56 with a firm fixed-price structure and an ultimate completion date of September 4, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical delivery order, demonstrating the company's role as a critical vendor within the federal medical supply chain. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. This comprehensive prime contract vehicle enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company's contract portfolio with the DLA reflects its capability to competitively fulfill federal procurement requirements across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 8/13/25 |